Genistein modulates proliferation and mitochondrial functionality in breast cancer cells depending on ERalpha/ERbeta ratio

Journal of Cellular Biochemistry

Volumn 115, Issue 5, 2014, Pages 949-958

  Pons, Daniel Gabriel ^a,b   Nadal Serrano, Mercedes ^a,b   Blanquer Rossello, M Mar ^a,b   Sastre Serra, Jorge ^a,b   Oliver, Jordi ^a,b   Roca, Pilar ^a,b  

^a Institut Universitari d'Investigació en Ciències de La Salut IUNICS   (Spain)

^b Instituto de Salud Carlos III   (Spain)

Author keywords

17 ESTRADIOL; APOPTOSIS; CELL CYCLE; CELL PROLIFERATION; ESTROGEN RECEPTORS; GENISTEIN; MITOCHONDRIA

Indexed keywords

CYTOCHROME C OXIDASE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENISTEIN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE;

APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CELL; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CELL CYCLE ARREST; CELL STRAIN MCF 7; CELLULAR PARAMETERS; CELLULAR, SUBCELLULAR AND MOLECULAR BIOLOGICAL PHENOMENA AND FUNCTIONS; CONTROLLED STUDY; ENZYME ACTIVITY; ESTROGEN RECEPTOR ALPHA ESTROGEN RECEPTOR BETA RATIO; HUMAN; HUMAN CELL; MITOCHONDRIAL DYNAMICS; MITOCHONDRIAL FUNCTIONALITY; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

17Β-ESTRADIOL; APOPTOSIS; CELL CYCLE; CELL PROLIFERATION; ESTROGEN RECEPTORS; GENISTEIN; MITOCHONDRIA;

BREAST NEOPLASMS; CELL PROLIFERATION; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENISTEIN; HUMANS; MCF-7 CELLS; MITOCHONDRIA;

EID: 84895553502     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24737     Document Type: Article

References (43)

1. Adams SM, Aksenova MV, Aksenov MY, Mactutus CF, Booze RM,. 2012. Soy isoflavones genistein and daidzein exert anti-apoptotic actions via a selective ER-mediated mechanism in neurons following HIV-1 Tat(1-86) exposure. PLoS ONE 7: e37540.
2. Adlercreutz H,. 2002. Phyto-oestrogens and cancer. Lancet Oncol 3: 364-373.
3. Bjornstrom L, Sjoberg M,. 2005. Mechanisms of estrogen receptor signaling: Convergence of genomic and nongenomic actions on target genes. Mol Endocrinol 19: 833-842.
4. Bouker KB, Hilakivi-Clarke L,. 2000. Genistein: Does it prevent or promote breast cancer Environ Health Perspect 108: 701-708.
5. Catlett-Falcone R, Landowski TH, Oshiro MM, Turkson J, Levitzki A, Savino R, Ciliberto G, Moscinski L, Fernandez-Luna JL, Nunez G, Dalton WS, Jove R,. 1999. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 10: 105-115.
6. Chang EC, Frasor J, Komm B, Katzenellenbogen BS,. 2006. Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells. Endocrinology 147: 4831-4842.
7. Chen J, Zeng J, Xin M, Huang W, Chen X,. 2011. Formononetin induces cell cycle arrest of human breast cancer cells via IGF1/PI3K/Akt pathways in vitro and in vivo. Horm Metab Res 43: 681-686.
8. Chrzanowska-Lightowlers ZM, Turnbull DM, Lightowlers RN,. 1993. A microtiter plate assay for cytochrome c oxidase in permeabilized whole cells. Anal Biochem 214: 45-49.
9. Davis DD, Diaz-Cruz ES, Landini S, Kim YW, Brueggemeier RW,. 2008. Evaluation of synthetic isoflavones on cell proliferation, estrogen receptor binding affinity, and apoptosis in human breast cancer cells. J Steroid Biochem Mol Biol 108: 23-31.
10. Gallo D, Zannoni GF, Apollonio P, Martinelli E, Ferlini C, Passetti G, Riva A, Morazzoni P, Bombardelli E, Scambia G,. 2005. Characterization of the pharmacologic profile of a standardized soy extract in the ovariectomized rat model of menopause: Effects on bone, uterus, and lipid profile. Menopause 12: 589-600.
11. Grandemange S, Herzig S, Martinou JC,. 2009. Mitochondrial dynamics and cancer. Semin Cancer Biol 19: 50-56.
12. Hoffman KL, Lerner SP, Smith CL,. 2013. Raloxifene inhibits growth of RT4 urothelial carcinoma cells via estrogen receptor-dependent induction of apoptosis and inhibition of proliferation. Horm Cancer 4: 24-35.
13. Imamov O, Morani A, Shim GJ, Omoto Y, Thulin-Andersson C, Warner M, Gustafsson JA,. 2004. Estrogen receptor beta regulates epithelial cellular differentiation in the mouse ventral prostate. Proc Natl Acad Sci USA 101: 9375-9380.
14. Kampa M, Notas G, Pelekanou V, Troullinaki M, Andrianaki M, Azariadis K, Kampouri E, Lavrentaki K, Castanas E,. 2012. Early membrane initiated transcriptional effects of estrogens in breast cancer cells: First pharmacological evidence for a novel membrane estrogen receptor element (ERx). Steroids 77: 959-967.
15. Klaunig JE, Kamendulis LM,. 2004. The role of oxidative stress in carcinogenesis. Annu Rev Pharmacol Toxicol 44: 239-267.
16. Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson JA,. 1997. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138: 863-870.
17. Lee YJ, Jeong SY, Karbowski M, Smith CL, Youle RJ,. 2004. Roles of the mammalian mitochondrial fission and fusion mediators Fis1, Drp1, and Opa1 in apoptosis. Mol Biol Cell 15: 5001-5011.
18. Manju V, Nalini N,. 2007. Protective role of luteolin in 1, 2-dimethylhydrazine induced experimental colon carcinogenesis. Cell Biochem Funct 25: 189-194.
19. Mantovani A, Allavena P, Sica A, Balkwill F,. 2008. Cancer-related inflammation. Nature 454: 436-444.
20. Messina MJ, Persky V, Setchell KD, Barnes S,. 1994. Soy intake and cancer risk: A review of the in vitro and in vivo data. Nutr Cancer 21: 113-131.
21. Miro AM, Sastre-Serra J, Pons DG, Valle A, Roca P, Oliver J,. 2011. 17beta-Estradiol regulates oxidative stress in prostate cancer cell lines according to ERalpha/ERbeta ratio. J Steroid Biochem Mol Biol 123: 133-139.
22. Morton MS, Arisaka O, Miyake N, Morgan LD, Evans BA,. 2002. Phytoestrogen concentrations in serum from Japanese men and women over forty years of age. J Nutr 132: 3168-3171.
23. Muthyala RS, Ju YH, Sheng S, Williams LD, Doerge DR, Katzenellenbogen BS, Helferich WG, Katzenellenbogen JA,. 2004. Equol, a natural estrogenic metabolite from soy isoflavones: Convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta. Bioorg Med Chem 12: 1559-1567.
24. Nadal-Serrano M, Sastre-Serra J, Pons DG, Miro AM, Oliver J, Roca P,. 2012. The ERalpha/ERbeta ratio determines oxidative stress in breast cancer cell lines in response to 17Beta-estradiol. J Cell Biochem 113: 3178-3185.
25. Nagamine MK, da Silva TC, Matsuzaki P, Pinello KC, Cogliati B, Pizzo CR, Akisue G, Haraguchi M, Gõrniak SL, Sinhorini IL, Rao KVK, Barbuto JAM, Dagli MLZ,. 2009. Cytotoxic effects of butanolic extract from Pfaffia paniculata (Brazilian Ginseng) on cultured human breast cancer cell line MCF-7. Exp Toxicol Pathol 61: 75-82.
26. Orlando L, Schiavone P, Cinieri S,. 2011. Genistein: The future of prevention and treatment of breast cancer Cancer Biol Ther 11: 918-920.
27. Parra V, Eisner V, Chiong M, Criollo A, Moraga F, Garcia A, Hartel S, Jaimovich E, Zorzano A, Hidalgo C, Lavandero S,. 2008. Changes in mitochondrial dynamics during ceramide-induced cardiomyocyte early apoptosis. Cardiovasc Res 77: 387-397.
28. Paruthiyil S, Parmar H, Kerekatte V, Cunha GR, Firestone GL, Leitman DC,. 2004. Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest. Cancer Res 64: 423-428.
29. Patisaul HB, Jefferson W,. 2010. The pros and cons of phytoestrogens. Front Neuroendocrinol 31: 400-419.
30. Ragan C, Wilson M, Darley-Usmar V, Lowe P,. 1987. Subfractionation of mitochondria and isolation of the proteins of oxidative phosphorylation. Oxford: IRL Press.
31. Rajah TT, Du N, Drews N, Cohn R,. 2009. Genistein in the presence of 17beta-estradiol inhibits proliferation of ERbeta breast cancer cells. Pharmacology 84: 68-73.
32. Rambold AS, Kostelecky B, Lippincott-Schwartz J,. 2011. Together we are stronger: Fusion protects mitochondria from autophagosomal degradation. Autophagy 7: 1568-1569.
33. Sastre-Serra J, Valle A, Company MM, Garau I, Oliver J, Roca P,. 2010. Estrogen down-regulates uncoupling proteins and increases oxidative stress in breast cancer. Free Radic Biol Med 48: 506-512.
34. Sastre-Serra J, Nadal-Serrano M, Pons DG, Roca P, Oliver J,. 2012a. Mitochondrial dynamics is affected by 17beta-estradiol in the MCF-7 breast cancer cell line. Effects on fusion and fission related genes. Int J Biochem Cell Biol 44: 1901-1905.
35. Sastre-Serra J, Nadal-Serrano M, Pons DG, Valle A, Oliver J, Roca P,. 2012b. The effects of 17beta-estradiol on mitochondrial biogenesis and function in breast cancer cell lines are dependent on the ERalpha/ERbeta ratio. Cell Physiol Biochem 29: 261-268.
36. Sastre-Serra J, Nadal-Serrano M, Pons DG, Roca P, Oliver J,. 2013. The over-expression of ERbeta modifies estradiol effects on mitochondrial dynamics in breast cancer cell line. Int J Biochem Cell Biol 45: 1509-1515.
37. Schleipen B, Hertrampf T, Fritzemeier KH, Kluxen FM, Lorenz A, Molzberger A, Velders M, Diel P,. 2011. ERbeta-specific agonists and genistein inhibit proliferation and induce apoptosis in the large and small intestine. Carcinogenesis 32: 1675-1683.
38. Siegel R, Ward E, Brawley O, Jemal A,. 2011. Cancer statistics 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61: 212-236.
39. Sotoca AM, Ratman D, van der Saag P, Strom A, Gustafsson JA, Vervoort J, Rietjens IM, Murk AJ,. 2008. Phytoestrogen-mediated inhibition of proliferation of the human T47D breast cancer cells depends on the ERalpha/ERbeta ratio. J Steroid Biochem Mol Biol 112: 171-178.
40. Yager JD, Liehr JG,. 1996. Molecular mechanisms of estrogen carcinogenesis. Annu Rev Pharmacol Toxicol 36: 203-232.
41. Youle RJ, van der Bliek AM,. 2012. Mitochondrial fission, fusion, and stress. Science 337: 1062-1065.
42. Yu JY, Lee JJ, Lim Y, Kim TJ, Jin YR, Sheen YY, Yun YP,. 2008. Genistein inhibits rat aortic smooth muscle cell proliferation through the induction of p27kip1. J Pharmacol Sci 107: 90-98.
43. Zhou JR, Mukherjee P, Gugger ET, Tanaka T, Blackburn GL, Clinton SK,. 1998. Inhibition of murine bladder tumorigenesis by soy isoflavones via alterations in the cell cycle, apoptosis, and angiogenesis. Cancer Res 58: 5231-5238.